Press Releases
Curis to Present at the Rodman & Renshaw 12th Annual Healthcare Conference
Business Wire | 1 hour 41 minutes ago
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the company will be presenting at the Rodman & Renshaw 12th Annual Healthcare Conference at 10:50 a.m. EDT on September 13, 2010, in New York City.... (more)
Kendall Law Group Investigates Allergan, Inc. for Shareholders
Business Wire | 4 hours 11 minutes ago
Kendall Law Group a national securities firm led by a former federal judge with attorneys that include a former U.S. Attorney, is investigating Allergan, Inc. (NYSE: AGN) for shareholders. The investigation concerns potential breaches of fiduciary duties by the board of directors and other company executives in connection to alleged violations of the False Claims Act. Concerned Allergan shareholders should contact the Kendall Law Group at 877-744-3728 or by email at skendall@kendalllawgroup.com.... (more)
XenoPort Announces New Employment Inducement Award
Business Wire | 9 hours 11 minutes ago
XenoPort, Inc. reported today that an equity award was made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employee was granted restricted stock units representing an aggregate of 750 shares of XenoPort's common stock. The restricted stock units vest in four equal annual installments on anniversaries of the September 1, 2010 grant date. The equity award was approved by the independent compensation committee of XenoPort’s board of director...... (more)
Life Technologies to Present at the UBS Global Life Sciences Conference
Business Wire | 9 hours 11 minutes ago
Life Technologies Corporation (NASDAQ:LIFE) today announced it will present at the UBS Global Life Sciences Conference on Wednesday, September 22 at 8:30 a.m. EDT. Greg Lucier, Life Technologies’ Chairman and Chief Executive Officer, will present on behalf of the company. The company will webcast the presentation, which will be available on the Life Technologies’ investor relations website for two weeks following the conference.... (more)
Emerald BioStructures and SomaLogic Enter Strategic Collaboration
Business Wire | 9 hours 11 minutes ago
Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers (“SOMAmers”) and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers. The research collaboration will leverage Emerald’s high-throughput X-ra...... (more)
ImmunoCellular Therapeutics Issues Letter to Shareholders
Business Wire | 9 hours 41 minutes ago
ImmunoCellular Therapeutics (OTCBB: IMUC) issued the following Letter to Shareholders today:... (more)
Gilead Sciences Submits European Marketing Application for Once-Daily Single-Tablet Regimen of Truvada and TMC278 for the Treatment of HIV Infection
Business Wire | 13 hours 41 minutes ago
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for marketing approval for the fixed-dose combination of Truvada® (emtricitabine and tenofovir disoproxil (as fumarate)) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine (as hydrochloride)) for the treatment of HIV-1 infection in adults. Pending approval, the new single-tablet...... (more)
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Allergan, Inc.
Business Wire | 21 hours 11 minutes ago
Law Offices of Howard G. Smith announces that it is investigating potential claims against Allergan, Inc. (“Allergan” or the “Company”) (NYSE:AGN) concerning possible breaches of fiduciary duty or other violations of law by the Company’s board of directors. Allergan is a multi-specialty healthcare company, engaged in the discovery, development, and commercialization of specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, ...... (more)
Novartis and collaborators discover novel antimalarial drug candidate
EurekAlert! | 1 day 1 hour 5 minutes ago
Published this week in Science the findings demonstrate that the antimalarial candidate, spiroindolone NITD609, is effective against both strains of the malaria parasite, Plasmodium (P.) falciparum and P. vivax. Through a novel mechanism NITD609 rapidly clears plasmodium in a malaria mouse model and shows pharmacological properties compatible with a once-daily dosing regimen.... (more)
Incyte to Present at Upcoming Investor Conferences
Business Wire | 1 day 1 hour 41 minutes ago
Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month of September:... (more)
Sequenom to Present at Two Financial Conferences in September
PRNewswire | 1 day 1 hour 41 minutes ago
SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that Ronald M. Lindsay, PhD, executive vice president of research and development, will present an overview of the company at the following conferences in September.... (more)
Celsion Receives SBIR Grant To Expand Its Technology Platform
PRNewswire | 1 day 3 hours 41 minutes ago
COLUMBIA, Md., Sept. 2 /PRNewswire-FirstCall/ --Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer". This funding will support the Company's efforts to develop its proprietary heat-activated liposomal technology in combination ...... (more)
BioDelivery Sciences Announces Positive Meeting with FDA on a Streamlined ONSOLIS REMS with Broadened Distribution
Business Wire | 1 day 4 hours 11 minutes ago
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced a positive meeting with the U.S. Food and Drug Administration (FDA), Meda and BDSI that occurred on Wednesday, July 21, 2010 to discuss significant modifications to the existing Risk Evaluation and Mitigation Strategy (REMS) program for ONSOLIS (fentanyl buccal soluble film).... (more)
Cell Publishes on the Critical Role of Metals in Alzheimer's Disease
MarketWire | 1 day 6 hours 11 minutes ago
MELBOURNE, AUSTRALIA -- (Marketwire) -- 09/02/10 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that Professor Ashley Bush, a co-founding scientist of Prana and a member of the Company's R&D Advisory Board, has in conjunction with the University of Melbourne, Australia, and Harvard Medical School, Boston, published an article that appears online today entitled: "Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's Disease" ...... (more)
Long Term Data Presented at ESC 2010 Shed Further Light on the Benefit of the CYPHER Sirolimus Drug-Eluting Stent Compared to the ENDEAVOR Zotarolimus-Eluting Stent in Important High-Risk Subgroups
Business Wire | 1 day 9 hours 41 minutes ago
Three new analyses of subgroups from the SORT OUT III study presented at the European Society of Cardiology (ESC) meeting in Stockholm, Sweden, provide additional detail on longer-term follow-up subgroup safety and efficacy outcomes in the SORT OUT III trial in three high-risk subgroups. These important data add detail to those already published in the March, 2010 issue of the Lancet on the clinical outcomes for the primary endpoint in the total population and in multiple subgroups at 9 month...... (more)
50 Press Releases | 
RSS Feed
Sign up for BIO SmartBrief
Latest Blog Postsview more
Death of the "doughnut"
Science Blog
Moonstruck primates: Owl monkeys need moonlight as much as a biological clock for nocturnal activity
Science Blog
Transition metal catalysts could be key to origin of life, scientists report
Science Blog
Transition metal catalysts could be key to origin of life, scientists report
Science Blog